Thomas Schinecker
Thomas Schinecker is the CEO of Roche, a leading global healthcare company. He is also a member of the board of the Lucerne Festival, where he contributes to the strategic direction of this renowned cultural institution.
Not in the pool (under ¢1).
Recent news mentions
Thomas Schinecker is the CEO of Roche and has been pivotal in the company's research and development efforts since his appointment in 2023.
Roche macht deutlich mehr Gewinn
Switzerland· 2026-01-29
Thomas Schinecker is the CEO of Roche and commented on the potential impact of US negotiations on drug prices.
Droht eine Verknüpfung mit den Medikamentenpreisen?Switzerland· 2026-01-17
Thomas Schinecker, the CEO of Roche, has made demands regarding drug pricing in Switzerland.
«Standortwettbewerb hat neue Dimension erreicht»Switzerland· 2025-12-24
Thomas Schinecker is the CEO of Roche who commented on the implications of the agreement with the US government.
Willkommener Weckruf für die SchweizSwitzerland· 2025-12-22Thomas Schinecker, the CEO of Roche, emphasized the geographical flexibility of global companies compared to Switzerland.
Schlaraffenland in Gefahr: Droht Basel der Pharma-Abschwung?Switzerland· 2025-11-08
Thomas Schinecker is the CEO of Roche and has been involved in the company's strategic decisions.
Warum Roche ins Stolpern gerät – und Novartis Vertrauen gewinntSwitzerland· 2025-09-01
Thomas Schinecker is the CEO of Roche and celebrated an event with apprentices at the Forum Buonas.
Dde Residenzen der Schweizer KonzerneSwitzerland· 2025-08-19
Thomas Schinecker is the CEO of Roche and was not present at a recent meeting in the White House.
Roche-Präsident Schwan zwischen Trump und Standort SchweizSwitzerland· 2025-08-13
Thomas Schinecker mentioned that prices could be halved by eliminating intermediaries.
Optionen für Roche und Novartis nach Trumps ZolldrohungenSwitzerland· 2025-08-06
Thomas Schinecker, chief executive officer of Roche Holding AG, told analysts that selling directly to consumers would be one of the easiest ways to impact pricing for the patient.
Trump demands drug companies lower prices in U.S. and raise them in other countries
Canada· 2025-08-01
Roche-CEO Thomas Schinecker expressed satisfaction with the operational results during the presentation of the half-year results.
viel Licht, aber auch SchattenSwitzerland· 2025-07-25
Thomas Schinecker, the CEO of Roche, hinted that the company's targets could be exceeded by the end of the year.
Aus Sorge um Zölle lässt Roche den Ausblick lieber unverändertSwitzerland· 2025-07-24CEO Thomas Schinecker has made the research of Roche more efficient.
Zehn Schweizer Aktien für die KauflisteSwitzerland· 2025-07-04
Thomas Schinecker, the CEO of Roche, noted that Switzerland is known for being expensive in many areas, but not for medications.
Schweiz soll höhere Preise für Medikamente bezahlenSwitzerland· 2025-04-29
Thomas Schinecker, the CEO of Roche, explained that the upcoming events would not significantly affect Roche.
Spediteure wie Kühne + Nagel gewannen, jetzt wackelt der WelthandelSwitzerland· 2025-04-25
Thomas Schinecker is the CEO of Roche and discussed investment plans during a recent earnings presentation.
Helvetia-Baloise-Fusion: Grätscht Zurich noch dazwischen?Switzerland· 2025-04-25
Chief Executive Thomas Schinecker said the investment underscored Roche’s commitment to the United States.
Roche to invest US$50-billion in U.S. to avoid Trump tariffs, create 12,000 jobsCanada· 2025-04-22
Thomas Schinecker is the CEO of Roche and emphasizes the company's growth in the pharmaceutical sector.
Diese Aktien aus Deutschland und der Schweiz bieten StabilitätSwitzerland· 2025-03-27
Thomas Schinecker is the CEO of Roche and a member of the foundation board.
Hauptsponsoren verlassen Lucerne Festival: Streit um ehemalige CS-ChefsSwitzerland· 2025-02-16
